Search results
Results from the WOW.Com Content Network
The most common cause of urinary retention is BPH. This disorder starts around age 50 and symptoms may appear after 10–15 years. BPH is a progressive disorder and narrows the neck of the bladder leading to urinary retention. By the age of 70, almost 10 percent of males have some degree of BPH and 33% have it by the eighth decade of life.
Urinary tract obstruction is a urologic disease consisting of a decrease in the free passage of urine through one or both ureters and/or the urethra. It is a cause of urinary retention . Complete obstruction of the urinary tract requires prompt treatment for renal preservation. [ 1 ]
However, bladder problems are most prevalent among older women. [79] Women over the age of 60 years are twice as likely as men to experience incontinence; one in three women over the age of 60 years are estimated to have bladder control problems. [73] One reason why women are more affected is the weakening of pelvic floor muscles by pregnancy. [80]
Without diagnostic evaluation, the cause of underactive bladder is unclear, as there are multiple possible causes. UAB symptoms can accurately reflect impaired bladder emptying due either to DU or obstruction (normal or large storage volumes, elevated post-void residual volume), or can result from a sense of incomplete emptying of a hypersensitive bladder (small storage volumes, normal or ...
Pregnant women are also at higher risk of developing UTI's, and in pregnant women, the development of UTI's can be quite dangerous; thus, it is highly advised for pregnant women to seek immediate care if experiencing significant signs and symptoms of a UTI. [28] Purple urine bag syndrome typically occurs as a result of bacterial infections.
Some people don’t experience any symptoms at all. Symptoms common in several types of cardiovascular disease include: Shortness of breath. Chest pain. Fatigue. Dizziness. Fainting. Fever ...
Prostatic artery embolization (PAE, or prostate artery embolisation) is a non-surgical technique for treatment of benign prostatic hyperplasia (BPH). [1]The procedure involves blocking the blood flow of small branches of the prostatic arteries using microparticles injected via a small catheter, [2] to decrease the size of the prostate gland to reduce lower urinary tract symptoms.
Diagram of stent placement. In A, the catheter is inserted across the lesion. In B, the balloon is inflated, expanding the stent and compressing the plaque. In C, the catheter and deflated balloon have been removed. Before-and-after cross sections of the artery show the results of the stent placement.